Anthony Partridge, PhDSenior Principal Scientist, Early Discovery Pharmacology at Merck, Sharp & Dohme
Dr. Anthony Partridge is a Senior Principal Scientist at MSD Singapore where he leads programs in the early discovery space. Previously, he was Senior Director of Biology at Pharmaron Beijing where he led a team focused on assay development/validation, screening, and built a world-class compound management facility. As an In Vitro Pharmacology Capability Lead at Merck, he pioneered collaborative efforts with pharmacology-based CRO partners. Prior to this, he was a Senior Scientist in the Pharmacology group at Merck Montreal. Dr. Partridge began his industry based career at Élan Pharmaceuticals in San Francisco.
Dr. Partridge has authored over twenty peer-reviewed scientific publications in top journals such as Cell, J. Clin. Invest., and JBC. He received his B.Sc. from the University of Guelph (1998), his Ph.D. from the University of Toronto (2003) and completed post-doctoral training at Scripps/UCSD (2003-2006).